New cancer clinical trial: Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer

Published on: October 30, 2018 at 11:00PM
Conditions:   Pancreatic Adenocarcinoma;   Stage III Pancreatic Cancer AJCC v8;   Stage IV Pancreatic Cancer AJCC v8
Interventions:   Biological: Pembrolizumab;   Biological: Wild-type Reovirus
Sponsors:   Northwestern University;   National Cancer Institute (NCI)
Not yet recruiting
https://ift.tt/2qimVdv Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer